Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Orthopedics Market Research

Soft Tissue Biologics Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Best Price Guarantee Length Publisher Published Date SKU
from $2,500 45 Pages GlobalData August, 2023 GBDT18184464
Best Price Guarantee
Price from $2,500
Length 45 Pages
Publisher GlobalData
Published Date August, 2023
SKU GBDT18184464

Soft Tissue Biologics Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Soft Tissue Biologics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Soft Tissue Biologics pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Soft Tissue Biologics are used in surgical procedures to replace, reinforce, or repair tendons or ligaments that have been torn or damaged in the human body.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Soft Tissue Biologics under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Soft Tissue Biologics and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Soft Tissue Biologics under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Soft Tissue Biologics Overview
4 Products under Development
4.1 Soft Tissue Biologics - Pipeline Products by Stage of Development
4.2 Soft Tissue Biologics - Pipeline Products by Segment
4.3 Soft Tissue Biologics - Pipeline Products by Territory
4.4 Soft Tissue Biologics - Pipeline Products by Regulatory Path
4.5 Soft Tissue Biologics - Pipeline Products by Estimated Approval Date
4.6 Soft Tissue Biologics - Ongoing Clinical Trials
5 Soft Tissue Biologics - Pipeline Products under Development by Companies
5.1 Soft Tissue Biologics Companies - Pipeline Products by Stage of Development
5.2 Soft Tissue Biologics – Companies Pipeline Products by Stage of Development
6 Soft Tissue Biologics Companies and Product Overview
6.1 Acuitive Technologies Inc Company Overview
6.1.1 Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Anika Therapeutics Inc Company Overview
6.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.3 BioGend Therapeutics Co Ltd Company Overview
6.3.1 BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.4 Colorado Therapeutics, LLC Company Overview
6.4.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.5 Columbia University Company Overview
6.5.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
6.6 Core Essence Orthopaedics, LLC Company Overview
6.6.1 Core Essence Orthopaedics, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.7 Georgia Institute of Technology Company Overview
6.7.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
6.8 New York R&D Center for Translational Medicine and Therapeutics Inc Company Overview
6.8.1 New York R&D Center for Translational Medicine and Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.9 Novadip Biosciences SA Company Overview
6.9.1 Novadip Biosciences SA Pipeline Products & Ongoing Clinical Trials Overview
6.1 Nutech Medical Inc Company Overview
6.10.1 Nutech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.11 OHSU Knight Cancer Institute Company Overview
6.11.1 OHSU Knight Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview
6.12 Osteopore International Pte Ltd Company Overview
6.12.1 Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.13 Shandong Junxiu Biotechnology Co Ltd Company Overview
6.13.1 Shandong Junxiu Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.14 STEL Technologies LLC Company Overview
6.14.1 STEL Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
6.15 Tissue Regenix Group PLC Company Overview
6.15.1 Tissue Regenix Group PLC Pipeline Products & Ongoing Clinical Trials Overview
6.16 University of Bielefeld Company Overview
6.16.1 University of Bielefeld Pipeline Products & Ongoing Clinical Trials Overview
6.17 University of Minnesota Company Overview
6.17.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
6.18 University of Missouri Company Overview
6.18.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
7 Soft Tissue Biologics- Recent Developments
7.1 Jan 23, 2023: Regenative Labs and Dr. Michael Lavor announce case study demonstrating novel application of umbilical cord flowable tissue allografts in decubitus ulcers
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Soft Tissue Biologics - Pipeline Products by Stage of Development
Table 2: Soft Tissue Biologics - Pipeline Products by Segment
Table 3: Soft Tissue Biologics - Pipeline Products by Territory
Table 4: Soft Tissue Biologics - Pipeline Products by Regulatory Path
Table 5: Soft Tissue Biologics - Pipeline Products by Estimated Approval Date
Table 6: Soft Tissue Biologics - Ongoing Clinical Trials
Table 7: Soft Tissue Biologics Companies - Pipeline Products by Stage of Development
Table 8: Soft Tissue Biologics – Companies Pipeline Products by Stage of Development
Table 9: Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Citrecuff - Product Status
Table 11: Citrecuff - Product Description
Table 12: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: HA Based Orthobiologic - Enthesis Repair - Product Status
Table 14: HA Based Orthobiologic - Enthesis Repair - Product Description
Table 15: HA Based Orthobiologic - Tendons/Ligaments - Product Status
Table 16: HA Based Orthobiologic - Tendons/Ligaments - Product Description
Table 17: BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 18: RevoCart - Product Status
Table 19: RevoCart - Product Description
Table 20: BioGend Therapeutics Co Ltd - Ongoing Clinical Trials Overview
Table 21: RevoCart - The Clinical Outcome of the Biphasic Cartilage Repair Implant (BiCRI) in the Treatment of Chondral and Osteochondral Lesions of the Knee.
Table 22: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Xenograft Implant - Orthopedic Foot - Product Status
Table 24: Xenograft Implant - Orthopedic Foot - Product Description
Table 25: Xenograft Implant - Orthopedic Knee - Product Status
Table 26: Xenograft Implant - Orthopedic Knee - Product Description
Table 27: Xenograft Implant - Orthopedic Shoulder - Product Status
Table 28: Xenograft Implant - Orthopedic Shoulder - Product Description
Table 29: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Bioengineered Skin Graft - Product Status
Table 31: Bioengineered Skin Graft - Product Description
Table 32: Core Essence Orthopaedics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Soft Tissue Repair Device - Extremities - Product Status
Table 34: Soft Tissue Repair Device - Extremities - Product Description
Table 35: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Prosthetic Device - ACL Replacement - Product Status
Table 37: Prosthetic Device - ACL Replacement - Product Description
Table 38: New York R&D Center for Translational Medicine and Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: TenoGen Scaffold - Product Status
Table 40: TenoGen Scaffold - Product Description
Table 41: Novadip Biosciences SA Pipeline Products & Ongoing Clinical Trials Overview
Table 42: NVD-002 - Product Status
Table 43: NVD-002 - Product Description
Table 44: Nutech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: ReNu - Product Status
Table 46: ReNu - Product Description
Table 47: Nutech Medical Inc - Ongoing Clinical Trials Overview
Table 48: ReNu - A Comparative Study of Injectable Human Amniotic Allograft (ReNu) Versus Corticosteroids for Plantar Fasciitis: A Prospective, Randomized, Blinded Study
Table 49: ReNu - A Phase 3 Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy of Amniotic Suspension Allograft (ASA) in Patients with Osteoarthritis of the Knee
Table 50: OHSU Knight Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 51: D-Printed Bricks - Bone Repair - Product Status
Table 52: D-Printed Bricks - Bone Repair - Product Description
Table 53: Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Orthopaedic Tendon Repair Implant - Product Status
Table 55: Orthopaedic Tendon Repair Implant - Product Description
Table 56: Shandong Junxiu Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Implantable Device - Bone Repair - Product Status
Table 58: Implantable Device - Bone Repair - Product Description
Table 59: Implantable Device - Sports Medicine - Product Status
Table 60: Implantable Device - Sports Medicine - Product Description
Table 61: STEL Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 62: ACL Graft - Product Status
Table 63: ACL Graft - Product Description
Table 64: Tissue Regenix Group PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Orthopure XT - ACL - Product Status
Table 66: Orthopure XT - ACL - Product Description
Table 67: Tissue Regenix Group PLC - Ongoing Clinical Trials Overview
Table 68: Orthopure XT - ACL - Post Market Clinical Follow-Up of OrthoPureXT for the Treatment of Multiligament Injured Knee: a Case Series
Table 69: University of Bielefeld Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Collagen - Bone Regeneration - Product Status
Table 71: Collagen - Bone Regeneration - Product Description
Table 72: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Orthopedic Meniscus Repair System - Product Status
Table 74: Orthopedic Meniscus Repair System - Product Description
Table 75: University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Bioactive Scaffold - Tissue Repair - Product Status
Table 77: Bioactive Scaffold - Tissue Repair - Product Description
Table 78: Glossary
2.2List of Figures
Figure 1: Soft Tissue Biologics - Pipeline Products by Stage of Development
Figure 2: Soft Tissue Biologics - Pipeline Products by Segment
Figure 3: Soft Tissue Biologics - Pipeline Products by Territory
Figure 4: Soft Tissue Biologics - Pipeline Products by Regulatory Path
Figure 5: Soft Tissue Biologics - Pipeline Products by Estimated Approval Date
Figure 6: Soft Tissue Biologics - Ongoing Clinical Trials

$2,500
$5,000
$7,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings